Literature DB >> 3337086

Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji.

J Tuomilehto1, P Zimmet, E Wolf, R Taylor, P Ram, H King.   

Abstract

Plasma uric acid was investigated in a population survey on diabetes and cardiovascular risk factors among Melanesians and Asian Indians in Fiji in 1980. Plasma uric acid levels were elevated in men and women with impaired glucose tolerance in both ethnic groups. The lowest plasma uric acid levels were found in diabetic patients, especially in diabetic men. Even though obesity was positively associated with plasma uric acid, it did not explain the high plasma uric acid level in persons with impaired glucose tolerance. Body mass index had a significant and independent impact on plasma uric acid levels both in nondiabetic and diabetic men and women. The strongest predictor of plasma uric acid in the multiple regression analysis in our study populations was plasma creatinine: it alone explained 9% of the variation in men and 2% in women; and 24% in Melanesians and 5% in Asian Indians. Our findings suggest a strong renal involvement in the balance of plasma uric acid and may also reflect certain dietary patterns, such as a high intake of protein, fats, and certain local vegetables. Although the prevalence of hyperuricemia was high, 27% in both Melanesian men and women, 22% in Asian Indian men, and 11% in Asian Indian women, clinical gout was uncommon. Many predictor variables and their interactions were analyzed along with the reasons for the high plasma uric acid levels in persons with impaired glucose tolerance and for the low plasma uric acid levels in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337086     DOI: 10.1093/oxfordjournals.aje.a114807

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  41 in total

1.  Prognostic significance of serum uric acid in acute myocardial infarction.

Authors:  Michael L Tuck; Dalila B Corry
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

2.  The association of hypomagnesaemia, high normal uricaemia and dyslipidaemia in the patients with diabetic retinopathy.

Authors:  Navin S; Krishnamurthy N; Ashakiran S; C D Dayanand
Journal:  J Clin Diagn Res       Date:  2013-09-10

3.  Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population.

Authors:  Stephen P Juraschek; Mara McAdams-Demarco; Edgar R Miller; Allan C Gelber; Janet W Maynard; James S Pankow; Hunter Young; Josef Coresh; Elizabeth Selvin
Journal:  Am J Epidemiol       Date:  2014-01-12       Impact factor: 4.897

4.  Relationship Between Serum Uric Acid and Incident Hypertension in Patients with Type 2 Diabetes.

Authors:  Mohsen Janghorbani; Heshmatollah Ghanbari; Ashraf Aminorroaya; Masoud Amini
Journal:  Rev Diabet Stud       Date:  2018-03-10

5.  Impact of diabetes against the future risk of developing gout.

Authors:  García Rodríguez; Lucia Cea Soriano; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2010-06-22       Impact factor: 19.103

6.  Serum uric acid and risk of incident diabetes in middle-aged and elderly Chinese adults: prospective cohort study.

Authors:  Di Cheng; Chunyan Hu; Rui Du; Hongyan Qi; Lin Lin; Xueyan Wu; Lina Ma; Kui Peng; Mian Li; Min Xu; Yu Xu; Yufang Bi; Weiqing Wang; Yuhong Chen; Jieli Lu
Journal:  Front Med       Date:  2020-04-29       Impact factor: 4.592

Review 7.  Problems related to definitions and epidemiology of type 2 (non-insulin-dependent) diabetes mellitus: studies throughout the world.

Authors:  K G Alberti
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

Review 8.  EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; T Bardin; E Pascual; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

9.  Hyperuricaemia and the metabolic syndrome in type 2 DM.

Authors:  Anthonia O Ogbera; Alfred O Azenabor
Journal:  Diabetol Metab Syndr       Date:  2010-04-20       Impact factor: 3.320

10.  Use of penalized splines in extended Cox-type additive hazard regression to flexibly estimate the effect of time-varying serum uric acid on risk of cancer incidence: a prospective, population-based study in 78,850 men.

Authors:  Alexander M Strasak; Stefan Lang; Thomas Kneib; Larry J Brant; Jochen Klenk; Wolfgang Hilbe; Willi Oberaigner; Elfriede Ruttmann; Lalit Kaltenbach; Hans Concin; Günter Diem; Karl P Pfeiffer; Hanno Ulmer
Journal:  Ann Epidemiol       Date:  2008-10-04       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.